04Mar
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums
In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By:
Foley & Lardner LLP
Related
On September 24, 2019, the Ohio Supreme Court announced the General Assembly has broad authority to ...
Read More >
Section 104(b)(4) of ERISA provides that a plan administrator must respond to a written request for ...
Read More >
Bill 108, the More Homes, More Choice Act, received Royal Assent on June 6, 2019. The Act amended 13...
Read More >
One of the foremost threats companies face today is that posed by cybercriminals, and the unique vul...
Read More >
On July 31, 2019, Illinois Governor J.B. Pritzker signed House Bill 834 into law, strengthening and ...
Read More >
On Tuesday, August 6, 2019, the United States Court of Appeals for the 5th Circuit held that the Equ...
Read More >